Driehaus Micro Cap Growth Fund (DMCRX)

Fund Assets	520.67M
Expense Ratio	1.407%
Min. Investment	$10,000
Turnover	142.00%
Dividend (ttm)	0.05
Dividend Yield	0.26%
Dividend Growth	-84.77%
Payout Frequency	Annual
Ex-Dividend Date	Dec 18, 2025

Previous Close	17.16
YTD Return	7.05%
1-Year Return	5.72%
5-Year Return	41.68%
52-Week Low	15.54
52-Week High	21.48
Beta (5Y)	1.22
Holdings	127
Inception Date	Nov 18, 2013

About DMCRX

The Driehaus Micro Cap Growth Fund is a mutual fund focused on maximizing capital appreciation through investments in U.S. micro-capitalization companies. The fund employs a growth-oriented strategy by primarily selecting equity securities, including common stocks, of companies whose market capitalizations fall within the range defined by the Russell Microcap® Growth Index at the time of investment. Its approach emphasizes identifying fundamentally strong businesses with substantial growth potential, often targeting firms at early stages of their corporate lifecycle. The fund's portfolio is diversified across numerous sectors, with healthcare, industrials, technology, and consumer cyclical industries featuring prominently. It maintains an actively managed process, leveraging bottom-up research to discover opportunities created by market inefficiencies and corporate inflection points. The fund is designed for long-term investors seeking exposure to dynamic, albeit volatile, areas of the U.S. equity market. While offering the prospect of higher returns due to its exposure to micro-cap growth stocks, the fund is also subject to heightened risks, including market volatility, liquidity constraints, and greater sensitivity to company-specific events compared to larger-cap funds.

• Fund Family: Driehaus
• Category: Small Growth
• Performance Rating: High
• Risk Rating: High
• Stock Exchange: Nasdaq
• Ticker Symbol: DMCRX
• Index: Russell Microcap Growth TR

Performance

DMCRX had a total return of 5.72% in the past year, including dividends. Since the fund's inception, the average annual return has been 17.06%.

Top 10 Holdings

20.00% of assets

Name	Symbol	Weight
Northern Institutional US Govt Sel	BGSXX	3.54%
Definium Therapeutics, Inc.	DFTX	2.53%
Spyre Therapeutics, Inc.	SYRE	2.48%
Praxis Precision Medicines, Inc.	PRAX	2.13%
nLIGHT, Inc.	LASR	1.75%
Kiniksa Pharmaceuticals International, plc	KNSA	1.58%
Bandwidth Inc.	BAND	1.55%
Lindblad Expeditions Holdings, Inc.	LIND	1.49%
Xometry, Inc.	XMTR	1.48%
MBX Biosciences, Inc.	MBX	1.47%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 18, 2025	$2.19903	Dec 18, 2025
Dec 19, 2024	$0.53839	Dec 19, 2024
Dec 13, 2023	$0.09711	Dec 14, 2023
Dec 14, 2022	$0.82383	Dec 14, 2022
Dec 16, 2021	$7.87639	Dec 17, 2021
Dec 17, 2020	$3.9562	Dec 17, 2020

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error